OrbiMed Genesis GP, Director: Terns Pharmaceuticals TERN Sell · Filed 24/07/17

Trade details

Type: Insider sale
Amount: $394,330
Shares · price: 39,433 sh · $10.00 a share
Held after: 4,843,421 sh
Stock: Terns Pharmaceuticals TERN
Person: OrbiMed Genesis GPDirector
Trade date: 24/07/15
Filed: 24/07/17
Days to filing: 2 days

Sold 0.8% of holdings

Share of holding sold: 0.8%

Terns Pharmaceuticals trades, last 26 weeks

What else happened in Terns Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/06/15~24/08/14

OrbiMed Genesis GP's recent trades

OrbiMed Genesis GPDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
OrbiMed Genesis GPDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
OrbiMed Genesis GPDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
OrbiMed Genesis GPDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
OrbiMed Genesis GPDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21

OrbiMed Genesis GP, Director — sold $394.3K of Terns Pharmaceuticals TERN · 0.8% of holdings · 10b5-1 plan | Whalegun